RIG-I activation by the delNS influenza vector boosts type I IFN and antigen presentation, but killing is mediated by HPV16 E6/E7-specific CD8+ T cells that lyse HPV16-positive tumor cells via MHC I; RIG-I-expressing cells are not specifically targeted.